Unitree Warns Humanoid Robot Industry Still in Early Commercialization Stage, Flags Stock Risks

Unitree Robotics, a Chinese humanoid robot manufacturer, announced that its stock price has experienced a cumulative deviation of over 30% in closing prices over three consecutive trading days. This surge constitutes an abnormal stock trading fluctuation, prompting the company to issue a risk warning to investors.

In a regulatory filing, the company stated that the humanoid robot industry is still in its early commercialization stage. It highlighted uncertainties in technology maturity, the cultivation of downstream market demand, and the supporting capabilities of the supply chain. These factors could hinder the pace of large-scale commercialization.

Unitree cautioned that if the industry's large-scale commercialization progresses slower than expected, its future revenue expansion and performance release may be adversely affected. The company also noted the potential risk of valuation regression, advising investors to be mindful of investment risks and to make rational decisions.

The announcement underscores the challenges facing the emerging humanoid robot sector, which requires significant time and investment in technology and market development to achieve widespread adoption.